X4 Pharmaceuticals, Inc. (XFOR) Social Stream



X4 Pharmaceuticals, Inc. (XFOR): $1.20

-0.07 (-5.51%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add XFOR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 397

in industry

X4 Pharmaceuticals Inc (XFOR) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering X4 Pharmaceuticals Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 7 $27 $15 $19.333 $2.03 852.36%
2021-12-14 7 $27 $11 $17.666 $2.03 770.25%
2021-12-16 7 $27 $10 $16.833 $2.03 729.21%
2021-12-19 7 $28 $10 $17 $2.03 737.44%
2022-01-03 7 $28 $10 $17.333 $2.03 753.84%
2022-03-18 7 $28 $10 $16.166 $2.03 696.35%
2022-03-21 7 $28 $10 $14.166 $2.03 597.83%

The Trend in the Analyst Price Target


XFOR's average price target has moved down $5.26 over the prior 27 weeks.

Over the past 50 weeks, XFOR's average upside potential has been 305.92%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-17 7 27 15 19.410 5.59 247.23%
2021-08-14 7 27 15 19.430 5.66 243.29%
2021-09-11 7 27 15 19.430 4.91 295.72%
2021-09-18 7 27 15 19.430 5.28 267.99%
2021-11-08 7 27 15 19.333 4.99 287.43%

XFOR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 7 0 0 0 0 7

The Trend in the Broker Recommendations


Over the past 151 days, XFOR's average broker recommendation rating improved by 0.62.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • X4 Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 883.24% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, X4 Pharmaceuticals Inc's variance in analysts' estimates is lower than -706.51% of them.
  • XFOR has a greater number of analysts covering the stock than 760.98% of stocks in the small market cap category.
  • In terms of how X4 Pharmaceuticals Inc fares relative to Healthcare stocks, note that its average analyst price target is greater than 254.11% of that group.

Stocks similar to X4 Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VYGR, VXRT, and VOR.

What is the outlook for XFOR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3706 seconds.